Prognostic Significance of U2AF1 Mutations in Myelodysplastic Syndromes: A Meta-Analysis

Journal of International Medical Research- United Kingdom

doi 10.1177/0300060519891013

Full Text

Abstract

Available in

Date

Authors

Publisher

SAGE Publications

Related search

Prognostic Role of TET2 Deficiency in Myelodysplastic Syndromes: A Meta-Analysis

Oncotarget
Oncology
2017English

Prognostic Significance of Monosomal Karyotype in Myelodysplastic Syndrome: A Meta-Analysis

Hematology
Hematology
2018English

Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2011English

U2AF1 Mutation Variants in Myelodysplastic Syndromes and Their Clinical Correlates

American Journal of Hematology
Hematology
2018English

Prognostic Significance of K-Ras Mutations in Pancreatic Cancer: A Meta-Analysis

World Journal of Surgical Oncology
SurgeryOncology
2016English

Cytogenetic Prognostic Factors in Myelodysplastic Syndromes

Hematology & blood transfusion: interdepartamental collection
2016English

Functional Significance of U2AF1 S34F Mutations in Lung Adenocarcinomas

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Myelodysplastic Syndromes: Histopathology as Prognostic Factor

Revista Brasileira de Hematologia e Hemoterapia
2001English

Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy